Blocknomi
Key Takeaways Shares of Abivax plummeted over 32% Tuesday following disclosure of Phase 3 data for obefazimod, an ulcerative colitis treatment that demonstrated exceptional effectiveness alongside rare cancer findings. The…
Related articles
-
Prediction market traders bet bitcoin's selloff has further to run
CoinDesk Published 03.06.2026 06:23
-
3 Altcoins Crypto Whales Are Buying Ahead of June 2026
BeInCrypto Published 29.05.2026 09:53
-
LIQUIFY DAO Joins Forces With Orix To Scale Customer Engagement, DeFi Cross-Chain With AI Agents
BlockchainReporter Published 02.06.2026 23:00
-
Dogecoin (DOGE) Under Pressure Again As Bears Eye Lower Levels
NewsBTC Published 27.05.2026 06:18
-
Liquidity Bifurcated: CLARITY Act Foreign Adversary Risk Premium Explained
Cryptonews Published 31.05.2026 09:38
-
Sleepagotchi – The Intelligence Layer for the Wellness Economy
Brave New Coin Published 01.06.2026 20:05
-
Canary Leads XRP ETF Gains as Bitcoin ETFs Lose $101M
Bitcoin.com Published 22.05.2026 18:06
-
Facet co-founder pitches EIP-8182 private transfers for inclusion in Ethereum’s Hegota upgrade
The Block Published 25.05.2026 10:38